Sleep Disorders Trial, Recruiting NCT06088810 Sponsor: Duke University Condition: Sleep Disorders
Back to Sleep Disorders

Sleep Disorders Trial, Recruiting

NCT06088810
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For people living with dementia:

  • People aged 60 or older
  • People who have been diagnosed with dementia by a doctor, or who report memory problems and score above a certain level on a standard memory assessment tool
  • People who score above 10 on a standard questionnaire that measures how severely sleep problems affect daily life
  • People who have been on a consistent, unchanged dose of medications that affect mood, behaviour, or sleep
  • People who are willing to wear a small wrist device that tracks sleep and movement throughout the study

For informal caregivers:

  • People aged 18 or older
  • People who provide at least 4 hours of care per day to a person living with dementia
  • People who live in the same home as the person they care for
  • People who can read and communicate in English

Who may not be able to join:

For people living with dementia:

  • People who have significant hearing difficulties
  • People who are planning to move into a residential care facility or nursing home within the next 3 months
  • People who have movement-related symptoms affecting muscle control, or who are experiencing sudden or severe sleep disturbances (confirm with trial site)
  • People who are unable to get out of bed independently
  • People who are currently living in a setting such as an assisted living community

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Darina Petrovsky, Duke University

Phone: 919-684-3786

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
3 April 2026
Est. completion
1 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Acceptability

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov